pyrazolo(3,4-d)pyrimidine has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botta, M; Casini, N; Ceccherini, E; Cutaia, O; Dreassi, E; Esposito, L; Forte, IM; Giordano, A; Indovina, P; Pentimalli, F; Polito, MS; Schenone, S; Zamperini, C | 1 |
1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Glioblastoma
| Article | Year |
|---|---|
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; src-Family Kinases | 2015 |